Plasma p-tau217 was measured in several cohorts by two types of test. It differentiates AD from controls and from related diseases. It outperforms plasma p-tau181, neurofilament light, and imaging markers. In one study, the marker identified people with the highest likelihood of Alzheimer’s disease, as judged by neuropathology of plaques and ...